Valuation: CVRx, Inc.

Market Cap 17.4M 15.87M 14.68M 13.24M 24.94M 1.63B 25.93M 177M 70.06M 878M 65.29M 63.93M 2.77B P/E 2026 *
-0.3x
P/E 2027 * -0.33x
Enterprise Value 34.75M 31.69M 29.3M 26.44M 49.81M 3.25B 51.77M 354M 140M 1.75B 130M 128M 5.53B EV / Sales 2026 *
0.62x
EV / Sales 2027 * 1.28x
Free-Float
85.36%
Yield 2026 *
-
Yield 2027 * -
1 day-1.15%
1 week-13.74%
Current month-57.16%
1 month-55.26%
3 months-78.04%
6 months-89.83%
Current year-91.49%
1 week 0.57
Extreme 0.5663
0.7
1 month 0.57
Extreme 0.5663
1.6
Current year 0.57
Extreme 0.5663
9.84
1 year 0.57
Extreme 0.5663
10.28
3 years 0.57
Extreme 0.5663
33.14
5 years 0.57
Extreme 0.5663
33.14
10 years 0.57
Extreme 0.5663
33.14
Manager TitleAgeSince
Chief Executive Officer 60 12/02/2024
Director of Finance/CFO 54 12/10/2026
Director of Finance/CFO 43 01/10/2020
Director TitleAgeSince
Director/Board Member 61 01/10/2008
Director/Board Member 57 01/07/2020
Director/Board Member 52 01/07/2020
Date Insider Type Main position Quantity % Market Cap. Importance
13/8/26 Buy

Chief Operating Officer

26,223 0.0988%
12/8/26 Sell

Chief Operating Officer

-1,309 0.0049%
1/6/26
Treo Ventures LLC
OtherCompany 0 0.0000% -
Change 5-day change 1-year change 3-year change Capi.($)
-1.15%-13.74%-93.47%-96.69% 17.4M
-0.22%-4.40%-19.63%+3.24% 181B
-1.56%-0.88%-0.08%+34.01% 125B
+0.19%-0.20%-11.51%+9.98% 121B
+1.12%-3.62%-42.71%+0.79% 90.52B
-0.64%-0.45%-3.69%+77.76% 66.9B
+0.31%+0.73%+12.35%-7.53% 58.68B
+1.19%-0.59%+4.22%+47.69% 54.38B
+0.86%-0.15%-1.84%+38.65% 48.46B
+0.84%+0.71%+1.50%-0.26% 35.4B
Average +0.05%-2.67%-15.49%+10.76% 78B
Weighted average by Cap. -0.07%-1.52%-10.43%+19.62%

Financials

2026 *2027 *
Net sales 56.4M 51.43M 47.56M 42.92M 80.83M 5.27B 84.01M 574M 227M 2.84B 212M 207M 8.98B 58.11M 52.99M 49M 44.22M 83.28M 5.43B 86.56M 592M 234M 2.93B 218M 213M 9.25B
Net income -55.76M -50.85M -47.02M -42.43M -79.91M -5.21B -83.06M -568M -224M -2.81B -209M -205M -8.88B -52.99M -48.33M -44.69M -40.33M -75.95M -4.95B -78.94M -540M -213M -2.67B -199M -195M -8.44B
Net Debt 17.35M 15.82M 14.63M 13.2M 24.86M 1.62B 25.84M 177M 69.83M 875M 65.08M 63.72M 2.76B 57.06M 52.03M 48.11M 43.42M 81.77M 5.33B 85M 581M 230M 2.88B 214M 210M 9.09B
Projected Income Statement - Annual - CVRx, Inc.
Logo CVRx, Inc.
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Employees
223
Date Price Change Volume
19/11/26 US$0.6040 -1.15% 198,157
17/11/26 US$0.6110 -0.33% 637,317
16/11/26 US$0.6130 +0.92% 514,365
13/11/26 US$0.6074 -3.60% 759,886
12/11/26 US$0.6301 -10.01% 591,873
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - CVRx, Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
0.6110USD
Average target price
1.650USD
Spread / Average Target
+170.05%
  1. Stock Market
  2. Stocks
  3. CVRX Stock